A clinical research network to improve the management of Monkeypox virus disease

Informazioni relative al progetto

MPX-RESPONSE

ID dell’accordo di sovvenzione: 101115188

DOI 10.3030/101115188

Data della firma CE 14 Aprile 2023

Data di avvio 5 Agosto 2022

Data di completamento 4 Agosto 2026

Finanziato da

• Health

Costo totale € 11 999 999,30

Contributo UE € 11 999 999,30

Coordinato da

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

Risultati finali

Documents, reports (2)

Guidelines on how to implement a centralised pharmacovigilance system

Describes how a centralised pharmacovigilance system is implemented

Safety Management Plan

Describes the governance the safety circuit and communication of the trial The safety communication between the trial safety group InsermANRSMIE and Sponsors representatives with the trial committees TCT TSC DSMB will be described